Peer Review History
| Original SubmissionJuly 4, 2019 |
|---|
|
PONE-D-19-18851 Hyponatraemia reversibly affects human myometrial contractility. An in vitro pilot study PLOS ONE Dear Authors, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by 31st October. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Salvatore Andrea Mastrolia, M.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: uploaded in file Moen Bruden 2019. Prior paper 2009 looked at oxytocin in multvar regression, but using 5 U total dose and bimodal analysis, showed .072 p value, although CI - .9 – 7.4. Thus, probably should not strongly say that oxytocin is not related to hyponatremia, as noted in this abstract. Not to review a 2009 publication, but excessive oxytocin may cause low Na in some patients. Also no mention of inappropriate ADH due to labor in either paper Phase plot reference 8 should be 10, page 14. The phase plot analysis proposed by the Warwick group actually was not intended primarily as a measure of effectiveness of contractions (especially in vivo), rather normalizing results among different samples. While customary in the field of uterine contractility, the area under the curve (AUC) is actually a force-time integration, which is a mechanical impulse. This unfortunately was also chosen decades ago as the word to describe an action potential, hence the potential (pun intended) confusion in a field where the tissue emits both an impulse in the form of an action potential and an impulse in the form of an integrated force. Just a comment, not a recommendation for change, since that boat left dock a while ago. If would be nice to occasionally see the correct terms used, however. Intro – • Should mention oxytocin at least as a possibility for causing hyponatremia • Cl- is largely distributed by passive electrical properties – donnan/Nernst • Intro describing the action potential is a bit long and the main point is only that these ions create electrical activity that “opens” voltage gated calcium channels which initiates the contraction. If you want to go into detail, you should also mention the Na/Ca exchanger which is probably more important in Na metabolism than the Na channel, esp regarding duration of contractions Sampling • 4 years to write manuscript? • Omit humanitarian or define it. Given the routine nature of this biopsy, we really don’t even need to know other than “clinical indications” and implying that none were done for research purposes alone. • Typo labouratory – “were” to where • Putting normonatraemic Tyrode’s once (earlier) is enough, redundant is redundant. Tyrode’s is normal Na. Also, you realize that Mg2+ is a potential tocolytic, probably should comment at some point. Most groups avoid Mg, although for these studies it probably makes no difference. For storage/transport on ice, you should mention pH, though since real Tyrode’s is ~ 6.5 unless outgassed with CO2 • Did you stabilized the 100 mg (9.8 mN) tension after tissue creep (i.e. rest period)? • You studied one biopsy at a time, although up to 8 strips simultaneously, correct? First part of the study • No need to repeat studying one biopsy at a time • Phase plot reference is Gullum – 10. My guess is that you need to use endnote or similar program, since it looks like several of your references are incorrectly numbered Second part of the study • No need to repeat studying one biopsy at a time • This description of oxytocin concentrations brings into question if the 82.5 nM oxytocin was used Solutions • While this is a complete description, it would be good to not repeat all the unchanged chemicals, but simply state the that the S solution was made hyponatremic and hypoosmotic by reduction of NaCl to 97.4 mM from 114 mM. Also, if oxytocin was added to the rest period (which I am not sure), you could place oxytocin here as well so that it is clear all tissues were exposed to oxytocin. On the other hand, if all tissues were not exposed to oxytocin, please correct your description on page 7 (top) Statistics • Do you mean “mean values for each biopsy..? – or each tissue strip? Results • Exclusion due to technical problems, or simply the tissue strip failed to contract (which can be up to 20% and still be OK) • Now you have to define humanitarian. I think you mean “elective” • Earlier you probably should note that none of your subjects were in spontaneous labor First part • First sentence is not a sentence • Needs to be really clear – peak force is the force change from “resting” to maximum force generated. (or however you measured) • Fig 1 is confusing. The 1 h is not clear. How many strips is this? Upper panel is noted, but not lower panel. Needs much better labeling • Fig 2. As above, amplitude is probably peak force, should note if measured from onset to peak or simply peak from absolute 0. • Fig 3 phase plots of the contractions above? • the really interesting finding is the oscillatory behavior in the lower 4 tracings in the lower panel – if only I could figure out the history of the tissues. Second part • This is confusing to read – could this just be a table? • All the figure legends should be put together at the end, near the figures. Discussion • This is where the concept of peak force rather than just force helps keep confusion with AUC (which to some is a force) low. • All changes were reversible in the…. Indicating that hyponatremia or hypoosmolarity … • Probably could mention Parkington’s work, but it is a bit overboard to attribute your results to spike-like rather than plateau potentials. • The paragraph that starts with tachysystole doesn’t hang together well. You never really got close to 5 contractions in 10 min, so I would suggest you avoid this topic • You really short-changed the discussion on the 2nd part of the study. What do you think caused multiphasic appearance? What is the physiological underpinning, and why would OT bring that out? • Pulsatile OT is neither here nor there -suggest you either justify or omit • What about multiphasic contractions in vivo – do your multiphasic relate to them (doubling, tripling, etc) • Given the effort on phase plots – they are also a way to quantify multiphasic behavior – that is the areas of the closed circles of the plots return a measure of the impulse attributable to each phase of the contraction. I actually don’t think this must be done because it is a lot of calculating for very little information, but just to point out that it could be done for the 2nd part oxytocin effects. Streghts (sic-type) and limitations • Our studies on excised human tissue may more closely represent the physiology of human labor better than rodent model. Or similar phrasing • OT was used to initiate contractions and establish a constant starting point to investigate the specific effects of hyponatremia/ hypoosmolarity on uterine contractions. • You already mention type II error, no need to have the last two lines as a limitation • The key limitation was that you studied hyponatremia without maintaining osmolarity constant, so the effects of Na are mixed with hypoosmolarity. However, since this is the clinical condition you wished to mimic, that may be what you intended to do. Conclusion • Some of the other factors for dystocia could be …. For example Sue Wray’s group showed that pH is a key factor as well. • Fluid intake was a conclusion of your prior paper, so you probably should merely say that low Na is a modifiable clinical parameter In summary This is a very good paper with very good data. While the philosophy of PLoS One is to publish data regardless of perceived relevance, this paper has both good data and relevance. As pointed out above, there are a few areas of potential confusion and a few missed opportunities. The authors should consider most of this review as suggestions, with questions requiring answers are written in bold. This manuscript satisfies PLoS One criteria for publication Reviewer #2: The present paper reports about the effect of hyponatremia on myometrial contractility, evaluated “in vitro” on myometrial biopsies obtained from women undergoing elective caesarean section at term. The authors conclude that hyponatremia present a reversible effect on myometrial contractility, since it may determine an increased frequency of contractions and of bi- or multiphasic contractions. The work is well written, and the reported results are indeed interesting, since it could explain the previously observed correlation between hyponatremia and instrumental delivery; however, I believe that the following points need to be addressed: • The authors should at least comment about the intrauterine resuscitation techniques and how they could affect the incidence of hyponatremia, in particular those who provide intravenous fluid bolus; indeed, in several countries, these tecniques are often used for the management of non-reassuring fetal heart monitoring. • Sometimes “hyponatremia” is written “hyponatraemia”, please correct. • Figure 1 and Figure 2 are hard to understand, please review to make them clearer • In the Discussion section more space must be given to the potential clinical implications of these findings: what could be the best method for hyponatremia correction? In an asymptomatic patient, when the electrolytes should be dosed? Only when there is a suspect of dystocic labor? Every three-four hours? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Hyponatraemia reversibly affects human myometrial contractility. An in vitro pilot study PONE-D-19-18851R1 Dear Authors, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Salvatore Andrea Mastrolia, M.D. Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All comments in inititial review are addressed. This is an interesting paper, with interesting approaches and analyses. There remain a few quibble points, but nothing that is clinically or scientifically important, hence will suggest accept in current form. Minor typo - page 9 could use a comma or something between 82.5 nM and 8.25. The the. Several more of these, but I think the copy editors will catch most. I find it interesting that you note that some hospitals administer D5W. I don't think many in the US do that (none in my experience). This would be an interesting study to compare outcomes in that group with matched D5LR group. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Roger C. Young, MD, PhD |
| Formally Accepted |
|
PONE-D-19-18851R1 Hyponatraemia reversibly affects human myometrial contractility. An in vitro pilot study Dear Dr. Moen: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Salvatore Andrea Mastrolia Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .